Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Arm B: Rituxan®/Mabthera®----1件: 46 💬
2Mabthera----20件: 11, 13, 35, 43, 44, 45, 46, 50, 51, 52, 53, 61, 63, 64, 65, 83, 162, 222, 223, 271 💬
3MabThera (Rituximab)1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬4件: 13, 46, 49, 53 💬
4MABTHERA - 1 FIALA 500 MG 50 ML----3件: 14, 53, 222 💬
5MABTHERA - 2 FIALE 100 MG 10 ML----2件: 19, 65 💬
6MabThera 100 mg concentrate for solution for infusion----1件: 222 💬
7MabThera 100mg----2件: 46, 222 💬
8MabThera 100mg concentrate for solution for infusion----1件: 222 💬
9MabThera 100mg, concentrate for solution for infusion----1件: 222 💬
10MabThera 500----1件: 271 💬
11MabThera 500 mg----1件: 46 💬
12MabThera 500 mg (10 mg/ml) concentrate for solution for infusion----1件: 46 💬
13MabThera 500 mg (10mg/ml)----1件: 46 💬
14MABTHERA 500 mg concentrado para solución para perfusión----1件: 46 💬
15MabThera 500 mg concentrate for solution for infusion----2件: 46, 222 💬
16MabThera 500 mg Konzentrat zur Herstellung einer Infusionslösung----1件: 46 💬
17MabThera 500mg----2件: 46, 222 💬
18Mabthera Infusion----1件: 83 💬
19MabThera infusions----1件: 46 💬
20Mabthera or biosimilar Rituximab1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬2件: 48, 61 💬
21Mabthera or biosimilar rituximab product1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
22MABTHERA*EV 1FL 50ML 500MG----3件: 46, 222, 223 💬
23MabThera/Rituxan----1件: 46 💬
24Mabthera®----7件: 13, 35, 43, 44, 46, 63, 93 💬
25MabThera® (rituximab)1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
26MabThera® 100MG----1件: 43 💬
27MabThera® 500MG----1件: 43 💬
28MabThera®, 100 mg Concentrado para solución para perfusión----1件: 46 💬
29MabThera®, 100 mg concentrate for solution for infusion----1件: 46 💬
30Originator rituximab - Rituxan ® or MabThera ®1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
31Prednisolone + mabthera1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 61 💬
32Rituxan (US, Canada, Japan), MabThera (rest of the world)----1件: 46 💬
33Rituxan (US, Canada, Japan), MabThera (rest of world)----1件: 53 💬
34Rituximab (MABTHERA and BIOSIMILARS)1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬2件: 35, 162 💬
35Rituximab (Mabthera ®) Belimumab (Benlysta ®)2件: Belimumab,
Rituximab		2件: Rituximab ,
Belimumab 💬 		2件: MS4A1,
TNFSF13B 💬 		5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 63 💬
36Rituximab (Mabthera)1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬2件: 14, 63 💬
37Rituximab (MABTHERA® or RITUXAN®).1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬3件: 35, 61, 63 💬
38Rituximab (Mabthera®)1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 61 💬
39Rituximab - MabThera1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
40Rituximab [MabThera/Rituxan]1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬2件: 46, 63 💬
41Rituximab [MabThera]1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
42Rituximab MabThera1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
43Rituximab, Mabthera1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 53 💬
44Rituximab/ Mabthera1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 271 💬